FEMASYS INC 8-K

What Happened Femasys Inc. announced that Nasdaq has granted the company a 180-day extension, until July 13, 2026, to regain compliance with Nasdaq Listing Rule 5550(a)(2) after its common stock had traded below the $1.00 minimum bid price. The company originally received the non-compliance notice on July 16, 2025 and requested the extension on January 12, 2026. Femasys told Nasdaq it had more than $5 million in stockholders’ equity as of December 31, 2025 and said it may effect a reverse stock split if needed to cure the deficiency.

Key Details

• Nasdaq non-compliance notice issued: July 16, 2025 (minimum bid price under $1.00 for 30 consecutive business days).
• Company requested extension: January 12, 2026; extension granted by Nasdaq: January 13, 2026.
• New compliance deadline: July 13, 2026 (180-day extension).
• Company reported > $5 million in stockholders’ equity as of December 31, 2025 and may pursue a reverse stock split to achieve a closing bid ≥ $1.00 for at least 10 consecutive business days.

Why It Matters The extension gives investors and the company additional time to restore the share price above Nasdaq’s $1.00 threshold and avoid potential delisting. If Femasys cannot meet the minimum bid price requirement by July 13, 2026, Nasdaq could initiate delisting procedures. The company’s mention of a possible reverse stock split is a common remedy to raise per-share price but can affect share count and market perception; investors should monitor future filings, any announced corporate actions, and the stock’s closing price.